A group of 42 US states and territories has filed a fresh antitrust lawsuit accusing Swiss pharma Novartis (NOVN: VX) and its former generics unit Sandoz (SIX: SDZ) of colluding to fix prices and ...

Market research group DelveInsight suggests the market for TIGIT inhibitors could expand sharply over the next decade, even ...

US biotech major Amgen announced financial results for the fourth quarter and full year of 2025 after markets closed on ...

Japanese drugmaker Astellas Pharma has announced top-line results from the STARLIGHT 2 Phase III pivotal study for ...

UK biotech Levicept, which is focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announced the appointment of James Sandy as chief development officer ...

US pharma giant Merck & Co (NYSE: MRK) has announced financial results for the fourth quarter and full year of 2025. Merck’s ...

Pfizer (NYSE: PFE) posted fourth-quarter 2025 revenue of about $18 billion, down 1% from the year-ago quarter, and adjusted ...

US pharma giant Pfizer today announced positive top-line results from the Phase IIb VESPER-3 study investigating monthly ...

The UK and Japan have announced a major package of science and technology collaborations, it has been announced.

Danish drugmaker Novo Nordisk has announced headline results from REIMAGINE 2, a Phase III study from the global REIMAGINE clinical trial program.

Cambridge, USA-based precision medicines specialist Relay Therapeutics today announced that the US Food and Drug ...

Norwegian cell therapy developer Zelluna (OSE: ZLNA) has promoted Emilie Gauthy to chief technology officer, effective immediately. Ms Gauthy joined the company in 2022 and has led manufacturing and ...